Fate Therapeutics stock price
페이트 테라퓨틱스NASDAQ:FATE · Nasdaq · Healthcare$2.32+0.87%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Fate Therapeutics last closed at $2.32 (+0.87%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -2.2×. Its overall grade ranks 409 of 739 stocks in Healthcare.
About this company
Fate Therapeutics last closed at $2.32 (+0.87%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B- · 409/739
Valuation grade C+
Related stocks
- PfizerCompetitor
세포치료·면역질환 파이프라인에서 대형 제약사 경쟁자
- Bristol-Myers SquibbCompetitor
세포치료 및 면역항암 분야에서 경쟁하는 글로벌 제약사
- NovartisCompetitor
CAR-T 등 세포치료 플랫폼 보유한 주요 경쟁사
About Fate Therapeutics
- What technical signals does Fate Therapeutics (FATE) have?
- Fate Therapeutics current technical signals: no active technical signal.
- Is Fate Therapeutics a cup-and-handle pattern?
- No. Fate Therapeutics has no valid Cup signal right now.
- What published figures are available for Fate Therapeutics?
- Market cap: $267.62M. Trailing 12 months PER: -2.2×. Latest quarter PBR: 1.82×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Fate Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy